Enhancement of memories by systemic administration of insulin-like growth factor II

Sarah A. Stern, Amy S. Kohtz, Gabriella Pollonini, Cristina Alberini

Research output: Contribution to journalArticle

Abstract

To treat cognitive disorders in humans, new effective therapies that can be easily delivered systemically are needed. Previous studies showed that a bilateral injection of insulin-like growth factor II (IGF-II) into the dorsal hippocampus of rats or mice enhances fear memories and facilitates fear extinction. Here, we report that, in mice, systemic treatments with IGF-II given before training significantly enhance the retention and persistence of several types of working, short-term and long-term memories, including fear conditioning, object recognition, object placement, social recognition, and spatial reference memory. IGF-II-mediated memory enhancement does not alter memory flexibility or the ability for new learning and also occurs when IGF-II treatment is given in concert with memory retrieval. Thus IGF-II may represent a potentially important and effective treatment for enhancing human cognitive and executive functions.

Original languageEnglish (US)
Pages (from-to)2179-2190
Number of pages12
JournalNeuropsychopharmacology
Volume39
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Insulin-Like Growth Factor II
Fear
Aptitude
Long-Term Memory
Executive Function
Therapeutics
Cognition
Hippocampus
Learning
Injections

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Enhancement of memories by systemic administration of insulin-like growth factor II. / Stern, Sarah A.; Kohtz, Amy S.; Pollonini, Gabriella; Alberini, Cristina.

In: Neuropsychopharmacology, Vol. 39, No. 9, 2014, p. 2179-2190.

Research output: Contribution to journalArticle

Stern, Sarah A. ; Kohtz, Amy S. ; Pollonini, Gabriella ; Alberini, Cristina. / Enhancement of memories by systemic administration of insulin-like growth factor II. In: Neuropsychopharmacology. 2014 ; Vol. 39, No. 9. pp. 2179-2190.
@article{310c99601cd14e6282d38793e78cf599,
title = "Enhancement of memories by systemic administration of insulin-like growth factor II",
abstract = "To treat cognitive disorders in humans, new effective therapies that can be easily delivered systemically are needed. Previous studies showed that a bilateral injection of insulin-like growth factor II (IGF-II) into the dorsal hippocampus of rats or mice enhances fear memories and facilitates fear extinction. Here, we report that, in mice, systemic treatments with IGF-II given before training significantly enhance the retention and persistence of several types of working, short-term and long-term memories, including fear conditioning, object recognition, object placement, social recognition, and spatial reference memory. IGF-II-mediated memory enhancement does not alter memory flexibility or the ability for new learning and also occurs when IGF-II treatment is given in concert with memory retrieval. Thus IGF-II may represent a potentially important and effective treatment for enhancing human cognitive and executive functions.",
author = "Stern, {Sarah A.} and Kohtz, {Amy S.} and Gabriella Pollonini and Cristina Alberini",
year = "2014",
doi = "10.1038/npp.2014.69",
language = "English (US)",
volume = "39",
pages = "2179--2190",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Enhancement of memories by systemic administration of insulin-like growth factor II

AU - Stern, Sarah A.

AU - Kohtz, Amy S.

AU - Pollonini, Gabriella

AU - Alberini, Cristina

PY - 2014

Y1 - 2014

N2 - To treat cognitive disorders in humans, new effective therapies that can be easily delivered systemically are needed. Previous studies showed that a bilateral injection of insulin-like growth factor II (IGF-II) into the dorsal hippocampus of rats or mice enhances fear memories and facilitates fear extinction. Here, we report that, in mice, systemic treatments with IGF-II given before training significantly enhance the retention and persistence of several types of working, short-term and long-term memories, including fear conditioning, object recognition, object placement, social recognition, and spatial reference memory. IGF-II-mediated memory enhancement does not alter memory flexibility or the ability for new learning and also occurs when IGF-II treatment is given in concert with memory retrieval. Thus IGF-II may represent a potentially important and effective treatment for enhancing human cognitive and executive functions.

AB - To treat cognitive disorders in humans, new effective therapies that can be easily delivered systemically are needed. Previous studies showed that a bilateral injection of insulin-like growth factor II (IGF-II) into the dorsal hippocampus of rats or mice enhances fear memories and facilitates fear extinction. Here, we report that, in mice, systemic treatments with IGF-II given before training significantly enhance the retention and persistence of several types of working, short-term and long-term memories, including fear conditioning, object recognition, object placement, social recognition, and spatial reference memory. IGF-II-mediated memory enhancement does not alter memory flexibility or the ability for new learning and also occurs when IGF-II treatment is given in concert with memory retrieval. Thus IGF-II may represent a potentially important and effective treatment for enhancing human cognitive and executive functions.

UR - http://www.scopus.com/inward/record.url?scp=84904462332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904462332&partnerID=8YFLogxK

U2 - 10.1038/npp.2014.69

DO - 10.1038/npp.2014.69

M3 - Article

C2 - 24642597

AN - SCOPUS:84904462332

VL - 39

SP - 2179

EP - 2190

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 9

ER -